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Abstract
Background: To objectively compare the early changes in vault over time following implantation of an Implantable
Collamer Lens without (ICL V4) and with (ICL V4c) a central hole and the respective factors affecting vault change in
moderate to high myopia.
Methods: This prospective study comprised of 38 eyes of 38 patients implanted with ICL V4 and 39 eyes of 39
patients implanted with ICL V4c intraocular lenses. We quantitatively assessed the postoperative values of vault and
pupil size at 1 day, 1 week, and 1 month following implantation using a rotating Scheimpflug camera (Pentacam).
We compared these postoperative values within and between the two groups and identified the factors affecting
vault change.
Results: The mean vaults at 1 day, 1 week, and 1 month following ICL V4 implantation were 303.68 ± 185.11, 517.
89 ± 160.07 and 521.32 ± 155.72 μm respectively, and those following ICL V4c were 316.67 ± 186.89, 495.13 ± 180.84
and 510.77 ± 175.51 μm, respectively. There was a significant difference in vault between 1 day and 1 week
postoperatively. There was a significant association between the vault change and the pupil size change in both
groups from 1 day to 1 month postoperatively (Pearman correlation coefficient; ICL V4: r = 0.585, P = 0.001; ICL V4c:
r = 0.588, P <0.001). The vault value 1 month after implantation of ICL V4 and ICL V4c was associated with the
preoperative anterior chamber depth, horizontal corneal diameter, horizontal and vertical sulcus-to-sulcus.
Conclusions: Pupil movement is a critical factor in vault change, with increasing vault observed postoperatively
from 1 day to 1 week associated with the declining effects of pharmacological miosis and increasing pupil size. The
anterior chamber depth, horizontal corneal diameter, horizontal and vertical sulcus-to-sulcus show some correlation
with vault.
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Background
The Visian Implantable Collamer Lens (ICL, Staar Surgical
Co.) is a posterior chamber phakic intraocular lens (pIOL)
that has been reported to be a safe and effective surgical
option for the correction of moderate to high myopia [1, 2].
Although the ICL offers outstanding advantages, there have
been reports in the literature of postoperative complica-
tions associated with both high and low degrees of vault of
the ICL over the crystalline lens. Low vault may lead to
mechanical contact with the crystalline lens or inadequate
aqueous circulation, which is responsible for a high inci-
dence of anterior capsular opacification and cataract forma-
tion [2–4]. Conversely, excessively high vault causes
mechanical contact between the ICL and the iris, resulting
in inflammation, high intraocular pressure, angle-closure
glaucoma and pigment dispersion syndrome [5].
Recently, a new implantable collamer lens (ICL V4c)
has become available, with a 360 μm central hole that
allows for the natural flow of aqueous humor without
the need for a peripheral iridotomy. This lens provides
excellent visual performance almost equivalent to that of
the conventional phakic IOL (ICL V4) and may reduce
the risk of anterior capsular opacification and cataract
formation [6–11].
Previous studies [12–15] have shown that the pupil
constriction in response to light can affect the vault, even-
tually causing the ICL to move posteriorly towards the
crystalline lens, leading to a significant decrease in central
vault under photopic conditions. Du et al. [16] reported
that the distance between the ICL and the crystalline lens
reduced as the ICL was moved posteriorly by the iris as a
result of pupil constriction during pharmacologic accom-
modation with topical pilocarpine. Simultaneously, the
anterior surface of the crystalline lens became more convex
and moved anteriorly, further reducing the central vault of
the ICL.
To the best of our knowledge, there is currently limited
literature available regarding early changes in and factors
affecting vault following conventional and hole ICL im-
plantation surgery. Considering that intraoperative miotic
agents have a relatively long-term effect on pupil constric-
tion, there is potentially significant effects on early vault
change following implantation of ICL V4 and ICL V4c
pIOLs. The purpose of the present study was to evaluate
the early changes in vault in the first month following ICL
V4 and ICL V4c implantation using a rotating Scheimpflug
camera (Pentacam) and assess the correlation between
vault changes and pupil size changes and investigate any
other relevant factors affecting vault.
Methods
Study population
This study was conducted in accordance with the princi-
ples of the Declaration of Helsinki and was approved by
the Ethics Committee of the Eye and ENT Hospital
Review Board of Fudan University. Written informed
consent was obtained from all patients after the nature
and possible consequences of the study were explained.
Thirty-eight eyes of 38 patients (12 males and 26
females) implanted with the ICL V4 pIOLs and 39 eyes
of 39 patients (12 males and 27 females) implanted with
the ICL V4c lens were included in this study. All patients
were treated for the correction of moderate to high my-
opia at the Eye and ENT Hospital of Fudan University,
Shanghai, People’s Republic of China.
Preoperative evaluation
A comprehensive ophthalmic examination was per-
formed preoperatively on all patients. The examinations
included uncorrected distance visual acuity (UDVA) and
corrected distance visual acuity (CDVA) using a Snellen
chart, manifest spherical and cycloplegic refractions, slit-
lamp biomicroscopic and fundoscopic examinations,
intraocular pressure (IOP, non-contact tonometer), cor-
neal topography (Pentacam, Oculus, Germany), central
corneal thickness (Pentacam), horizontal corneal diam-
eter (white-to-white, WTW, IOL master, Carl Zeiss,
Germany), axial length (A-scan ultrasound), anterior
chamber depth (ACD, Pentacam, measured from the
corneal endothelium to the anterior lens), corneal endo-
thelial cell density (ECD, noncontact specular micros-
copy, SP-2000P, Topcon Corporation, Japan), optical
coherence tomography (OCT, Optovue, USA), and ultra-
sound biomicroscopy (UBM, Quantel medical, France).
Inclusion criteria for this study included patient age be-
tween 18 and 45 years, myopia between −0.50 and −21.00
DS, astigmatism between 0 and −6.00 DC, anterior cham-
ber depth (ACD) of 2.80 mm or more, and an endothelial
cell density greater than 2000 cells/mm2. Patients were also
required to have a reasonable expectation of surgical out-
comes, no preexisting ocular pathology, no previous kera-
toconus, cataract or glaucoma, and no systemic disease.
Implantable Collamer Lens calculation
The ICL is a plate-haptic single-piece intraocular lens
made of collamer, which is a flexible, hydrophilic mater-
ial consisting of HEMA Hydrogel, water, and porcine
collagen. It can be folded and implanted in the posterior
chamber via a 2.8–3.2 mm corneal incision. It has a high
degree of biocompatibility, good permeability of gases
and metabolites, and good absorption of ultraviolet radi-
ation. The ICL design has been modified many times in
the past. In this study, the phakic IOL patients were
implanted with either the ICL V4 or the ICL V4c lens
designs. The ICL V4 is a 6.0 mm wide lens and comes in
four sizes (11.5, 12.0, 12.5 and 13.0 mm in length). The
lens has a central convex–concave optic zone with a
diameter of 4.5–6.0 mm, a spherical power range of
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−3.00 to −23.00 DS and a cylindrical power range of
+1.00 to +6.00 DC. The ICL V4c is a 6.00 mm wide lens
and comes in four sizes (12.1, 12.6, 13.2 and 13.7 mm in
length). Its optic zone diameter is 4.9–5.8 mm, with a
spherical power range of - 0.50 to - 18.00 DS and a cylin-
drical power range of +0.50 to +6.00 DC.
ICL power calculations were performed by the manufac-
turer (STAAR Surgical) using a modified vertex formula.
The variables in the formula included preoperative manifest
spherical and cycloplegic refractions, keratometric power,
central corneal thickness and central ACD. The size
(length) of the implanted ICL was determined based on the
patient’s WTW and ACD. In principle for the ICL V4,
when the ACD was 2.80 ~ 3.00 mm, ICL length =WTW+
0.2 ~ 0.4 mm; when the ACD was 3.00 ~ 3.50 mm, ICL
length =WTW+0.4 ~ 0.6 mm; when the ACD was 3.50 ~
3.70 mm, ICL length =WTW+0.6 ~ 0.8 mm. For the ICL
V4c, the sizes (lengths) of 12.1, 12.6, 13.2 and 13.7 mm
were equal to the ICL V4 sizes (lengths) of 11.5, 12.0, 12.5
and 13.0 mm, respectively.
ICL surgical procedure
Preoperative peripheral iridotomies by neodymium - yt-
trium - aluminum - garnet (Nd:YAG) laser or intraopera-
tive peripheral iridotomies were performed for ICL V4
implantations and no peripheral iridotomies were per-
formed for ICL V4c implantations. On the day of surgery,
all patients were administered with dilating and cyclople-
gic agents (2.5 % phenylephrine and 1 % tropicamide,
Alcon, China). After topical anaesthesia (0.4 % oxybupro-
caine hydrochloride, Santen, Japan) and injection of a
viscoelastic surgical agent (1.7 % Sodium hyaluronate;
Bausch & Lomb, China) into the anterior chamber, an ICL
V4 IOL was inserted via a 2.8–3.2 mm temporal clear cor-
neal incision with the use of an injector cartridge (STAAR
Surgical). After the ICL was placed in the posterior cham-
ber, the surgeon then completely removed the viscoelastic
surgical agent from the eye using a balanced salt solution
and instilled a miotic agent (0.005 % carbachol, Bausch &
Lomb, China). All surgeries were uneventful and no intra-
operative complications were observed. Following surgery,
a combination antibacterial and steroidal medication
(0.1 % Tobramycin dexamethasone, Alcon, China) was
prescribed four times daily for 3 days followed by fluoro-
metholone eyedrops tapered gradually over 2 weeks. Anti-
biotic eyedrops (0.5 % left Ofloxacin, Santen, Japan) were
then prescribed four times daily for 1 week, along with
non-steroidal anti-inflammatory eyedrops (NSAID, prano-
profen, Senju, Japan) four times daily for 2 weeks, and arti-
ficial tears four times daily for 1 month.
Measurement of vault
The central vault is the distance between the back sur-
face of the ICL and the front surface of the crystalline
lens. It was quantitatively measured postoperatively at
1 day, 1 week, and 1 month after surgery using a rotat-
ing Scheimpflug camera (Pentacam, Oculus, Germany)
with the patient’s chin placed on the chin rest and the
forehead against the forehead strap. The patient was
asked to open both eyes and fixate on the blue fixation
target in the center of the black background. Twenty-
five Scheimpflug images were automatically recorded
within 2 s once perfect alignment was obtained. Image
quality was checked using the quality factor value for
each eye. An experienced examiner who was blind to the
patients measured the central vault value from the
Pentacam overview diagram using the image analysis
software program accompanying the device. The vault
was measured centered on the optical axis, which was
shown as a white dotted line on the screen. The pupil
size was automatically measured by the Pentacam de-
vice. All measurements of the ICL V4 and ICL V4c vault
were taken under the same mesopic conditions.
Statistical analysis
All statistical analyses were performed using SPSS version
20.0 (SPSS Inc., IBM, USA) and results are expressed as
mean ± standard deviation (SD). The Kolmogorov-Smirnov
test was chosen to confirm the normal distribution of the
data. For comparison between eyes with ICL V4c versus
ICL V4 implantation, independent t tests were conducted
for parameters with continuous variables. Repeated mea-
sures analysis of variance (ANOVA) with bonferroni-
adjusted post hoc comparisons was performed to evaluate
differences in variables post operation. Stepwise multiple
regression analysis was performed to investigate the correl-
ation between several variables and the vault at 1 month
after surgery. The dependent variable was the central vault,
and the independent variables included patient age, pre-
operative refraction, horizontal corneal diameter (WTW),
horizontal and vertical sulcus-to-sulcus (STS) distance,
ACD, axial length, keratometric readings and ICL power.
P <0.05 was considered statistically significant.
Results
The demographics of the preoperative parameters are
summarized in Table 1. All surgical procedures were un-
eventful and no postoperative complications were observed
during the observation period. The postoperative changes
in vault and pupil size of all eyes after implantation with
ICLV4 and ICLV4c pIOLs are presented in Table 2.
The time courses of the phakic IOL vaults in the two
groups are shown in Fig. 1. For the two groups, there were
significant differences between the vault at 1 day and
1 week after surgery (P <0.001) and the vault between
1 day and 1 month (P <0.001). There was no significant
difference between the vault at 1 week and 1 month after
surgery (P = 1.00, P = 0.07, respectively). There was also
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no significant difference in vault between the ICL V4 and
ICL V4c groups postoperatively.
The time course of pupil size change in the two
groups is shown in Fig. 2. For the two groups, there were
significant differences between the values at 1 day and
1 week after surgery (P <0.001), and between 1 day and
1 month after surgery (P <0.001). There was no significant
difference in pupil size between 1 week and 1 month after
surgery (P = 1.00). There was also a significant difference
in pupil size between the ICL V4 and ICL V4c groups
postoperatively at 1 day (P <0.001), however there was no
significant difference between the two groups postopera-
tively at 1 week or 1 month (P = 0.10).
The correlation between the short-term changes in
vault and pupil size immediately after surgery were eval-
uated. There was a significant association between the
vault changes and the pupil size changes in both the ICL
V4 and ICL V4c groups from 1 day postoperatively to
Table 1 Demographics of preoperative parameters
Parameter ICL V4 ICL V4c P value
N, eyes 38 39
Age, years 28.66 ± 7.53(20 ~ 45) 28.69 ± 6.44(20 ~ 45) 0.98
UDVA (Snellen lines) 0.06 ± 0.04(0.01 ~ 0.15) 0.07 ± 0.06(0.01 ~ 0.15) 0.29
CDVA (Snellen lines) 0.94 ± 0.17(0.50 ~ 1.20) 0.97 ± 0.15(0.7 ~ 1.20) 0.39
Refractive errors (D)
Spherical −11.97 ± 3.46(−5.25 ~ −20.50) −11.72 ± 3.58(−7.25 ~ −20.25) 0.76
Cylindrical −1.34 ± 1.02(0 ~ −4.75) −1.47 ± 1.10(−0.25 ~ −5.00) 0.59
Spherical equivalent −12.64 ± 3.60(−5.75 ~ −21.38) −12.46 ± 3.67(−7.75 ~ −22.00) 0.83
Keratometric value (D)
Flat K 43.39 ± 1.73(38.3 ~ 46.7) 43.12 ± 1.74(39.4 ~ 46.7) 0.51
Steep K 44.60 ± 2.03(38.7 ~ 49.2) 44.52 ± 1.87(41.2 ~ 49.0) 0.86
STS (mm)
Vertical 12.36 ± 0.43(11.54 ~ 13.33) 12.36 ± 0.68(10.67 ~ 13.75) 0.98
Horizontal 11.76 ± 0.37(11.12 ~ 12.64) 11.81 ± 0.62(10.31 ~ 13.39) 0.68
IOP (mm Hg) 14.08 ± 2.38(8.8 ~ 19.1) 15.20 ± 2.70(9.9 ~ 20.1) 0.57
Axial length (mm) 28.24 ± 1.78(25.01 ~ 31.49) 28.24 ± 1.78(25.42 ~ 32.19) 0.99
WTW diameter (mm) 11.77 ± 0.34(11.2 ~ 12.5) 11.85 ± 0.49(10.7 ~ 12.7) 0.39
ACD (mm) 3.21 ± 0.23(2.83 ~ 3.70) 3.18 ± 0.19(2.87 ~ 3.70) 0.86
CCT (mm) 521.08 ± 35.70(467 ~ 603) 515.51 ± 22.26(469 ~ 572) 0.12
ECD (cells/mm2) 3254.18 ± 366.74(2331 ~ 3951) 3270.18 ± 351.21(2374 ~ 4258) 0.85
Pupil size (mm) 3.38 ± 0.74(2.09 ~ 4.48) 3.14 ± 0.60(2.14 ~ 4.42) 0.52
ICL size (mm) 12.36 ± 3.84(11.5 ~ 13.0) 12.97 ± 0.47(12.1 ~ 13.7)
ICL power (D) −15.16 ± 7.22(−8.50 ~ −23.00) −12.62 ± 2.92(−8.50 ~ −18.00)
Results are expressed as means ± standard deviation (range)
N number of eyes, UDVA uncorrected distance visual acuity, CDVA corrected distance visual acuity, D diopters, K keratometry, STS sulcus to sulcus, IOP intraocular
pressure, WTW horizontal white-to-white diameter, ACD anterior chamber depth, CCT central corneal thickness, ECD corneal endothelial cell density, ICL
implantable collamer lens
Table 2 Postoperative vault and pupil size in eyes undergoing implantation of ICL V4 and ICL V4c
Parameter ICL V4 ICL V4c
Time course 1 day 1 week 1 month 1 day 1 week 1 month
Pupil size (mm)
Mean ± SD 1.82 ± 0.66 3.50 ± 0.70 3.59 ± 0.68 2.43 ± 0.76 3.26 ± 0.45 3.31 ± 0.53
Range 1.02 ~ 3.63 2.01 ~ 5.54 2.31 ~ 5.52 1.21 ~ 3.95 2.11 ~ 4.75 2.23 ~ 4.84
Vault (um)
Mean ± SD 303.68 ± 185.11 517.89 ± 160.07 521.32 ± 155.72 316.67 ± 186.89 495.13 ± 180.84 510.77 ± 175.51
Range 0 ~ 680 270 ~ 920 290 ~ 980 0 ~ 690 150 ~ 850 190 ~ 860
ICL implantable collamer lens, SD standard deviation
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1 month postoperatively. (Pearman correlation coefficient;
ICL V4: r = 0.585, P =0.001; ICL V4c: r = 0.588, P <0.001,
respectively) (Fig. 3).
The results of multiple regression analyses are shown
in Table 3. The independent variable relevant to the
vault in the two group was ACD (R2 = 0.357, P <0.001;
R2 = 0.316, P = 0.001, respectively). The multiple regres-
sion equation was expressed as follows: ICL V4 Central
vault (μm) = (386.51 * ACD) - 718.77, ICL V4c Central
vault (μm) = (503.43 * ACD) - 1075.64, respectively. The
standardized partial regression coefficient was calculated
to determine the magnitude of each variable’s influence.
Apart from ACD, the WTW, horizontal and vertical STS
were also relevant variables to the vault in the two
groups. The central vault was positively correlated with
WTW of the two groups (Pearman correlation coefficient;
ICL V4: r = 0.440, P = 0.006; ICL V4c: r= 0.366, P = 0.022,
respectively), horizontal STS (ICL V4: r = 0.355, P = 0.029;
ICL V4c: r =0.365, P = 0.022, respectively), and vertical STS
(ICL V4: r = 0.345, P = 0.034; ICL V4: r = 0.344, P = 0.032,
respectively). The relationships between vault and ACD,
WTW, horizontal and vertical STS are shown in Figs. 4, 5,
6 and 7, respectively. There was no significant correlation
shown with any other factors.
Discussion
Implantable collamer lenses are a safe and effective
phakic IOL option for the surgical correction of moder-
ate to high myopia. In the present study, we aimed to
assess the early changes in phakic IOL vault in the first
month immediately after implantation of ICLs, both
without and with a central hole. We measured patient
age, preoperative refraction, horizontal corneal diameter
(WTW), horizontal and vertical sulcus to sulcus
distance, ACD, axial length, keratometric readings, ICL
power, postoperative phakic IOL vault and pupil size, the
phakic IOL vault changes and the pupil size changes of
eyes following implantation of ICL V4 and ICL V4c
IOLs. Our results demonstrated a significant increase in
vault postoperatively from 1 day to 1 week after implant-
ation of both ICL V4 and ICL V4c IOLs, which then
remained stable from 1 week onwards in both groups.
We found that the change in pupil size was a critical
factor to the vault change, and postoperative vault was
associated with preoperative ACD, WTW, horizontal
and vertical STS in eyes implanted with ICL V4 and ICL
Fig. 1 Time course of the phakic IOL vaults in the two groups
following implantation of ICL V4 and ICL V4c. (***P <0.001)
Fig. 2 Time course of pupil size in the two groups following
implantation of ICL V4 and ICL V4c. (***P <0.001)
Fig. 3 Correlation of vault changes and pupil size changes in the
ICL V4 and ICL V4c groups from 1 day postoperatively to 1 month
postoperatively. (Pearman correlation coefficient; ICL V4: r = 0.585,
P = 0.001, y = 159.0 x − 51.3; ICL V4c: r = 0.588, P <0.001, y = 118.5
x + 89.8, respectively)
Table 3 Results of Stepwise Multiple Regression Analyses of ICL









Anterior chamber depth (mm) 386.51 0.562 <0.001
Constant −718.77 0.02
R2 = 0.357, Adjusted R2 = 0.320
ICL V4c
Anterior chamber depth (mm) 503.43 0.518 0.001
Constant −1075.64 0.02
R2 = 0.316, Adjusted R2 = 0.297
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V4c. In recent studies, rotating Scheimpflug imaging
(Pentacam) [17–19], anterior segment OCT [4, 13, 20,
21], and UBM [22] have been used to measure the
phakic IOL vault and have all provided accurate and
reproducible measures of anterior segment biometry. In
our present study, we used the rotating Scheimpflug
imaging system (Pentacam) that has proved to be a re-
peatable measurement to evaluate the vault [17].
Previous studies [4, 5, 17–19, 23] investigating vault
following ICL implantation have demonstrated a ten-
dency for the vault to decrease slightly in the long term
for both conventional ICLs and hole ICLs. Currently,
there is limited literature available investigating changes
in vault as early as 1 day following implantation of ICL
V4c IOLs. One study by Kamiya et al. [17] reported the
comparison of vault following implantation of both ICL
V4 and ICL V4c from 1 week to 6 months postopera-
tively. This study, however, measured the central vault
when the pupil was dilated and vault 1 day after the sur-
gery was not measured, so the vault likely have increased
slightly due to a larger pupil size. In contrast, the design
and outcomes of our present study more closely reflect
the natural process after surgery. Another study by
Kojima et al. [21] investigating vault changes after the
implantation of conventional ICLs over a 1-year period
demonstrated a statistically significant decrease in vault
from 1 day to 3 months after surgery, with vault stabiliz-
ing after 3 months. This study, however, did not report
the effects of changes in pupil size on vault, in particular
at 1 day postoperatively, which may partly explain the
difference in results between their findings and ours.
This is important as the prolonged effects of the miotic
agents used intraoperatively are likely to have contrib-
uted to the short term changes in vault due to pupil size
changes, with our study demonstrating a statistically
significant difference in postoperative pupil size between
1 day and all other time points after both ICL V4 and
ICL V4c implantation.
The miotic agent was used for every eye implanted
with the ICL V4 IOL to allow for the flow of aqueous
humor through the peripheral iridotomy. Not every eye
implanted with the ICL V4c required a miotic agent be-
cause of the presence of the central hole, contributing to
the significant difference in pupil size observed between
the ICL V4 and ICL V4c groups 1 day postoperatively.
The vault after ICL V4c implantation was essentially
equivalent to the vault after ICL V4 implantation, sug-
gesting that the presence of the central hole did not
Fig. 4 Correlation between anterior chamber depth and the central
vault in the ICL V4 and ICL V4c groups (r = 0.562, P <0.001; r = 0.524,
P = 0.001, respectively)
Fig. 5 Correlation between white-to-white and the central vault in
the ICL V4 and ICL V4c groups (r = 0.440, P = 0.006; r = 0.366,
P = 0.022, respectively)
Fig. 6 Correlation between horizontal sulcus to sulcus and the central
vault in the ICL V4 and ICL V4c groups (r= 0.355, P= 0.029; r =0.365,
P= 0.022, respectively)
Fig. 7 Correlation between vertical sulcus to sulcus and the central
vault in the ICL V4 and ICL V4c groups (r = 0.345, P = 0.034; r = 0.344,
P = 0.032, respectively)
Chen et al. BMC Ophthalmology  (2016) 16:161 Page 6 of 9
significantly affect the postoperative vault. With regards
to the short term changes after surgery, we found a sig-
nificant association between the vault changes and the
pupil size changes from 1 day to 1 month after the im-
plantation of both ICL V4 and ICL V4c IOLs, conclud-
ing that pupil size change is a critical factor in vault
change, which is consistent with previous relevant stud-
ies [12–16, 18, 24]. We also found a relatively high vault
1 day after surgery in a select number of eyes with small
pupils. We inferred that the residual viscoelastic agent
played a significant role in the relatively high vault in
these eyes 1 day after surgery, as the vault then de-
creased as the viscoelastic agent was removed by aque-
ous humor circulation.
There are several factors that may affect the vault after
ICL implantation, as reported by Kamiya et al. [18, 24],
including pupil movement, age-related increases in crys-
talline lens thickness and the fixed position of the ICL
haptics. Several studies [12–15] have shown that pupil
constriction leads to a significant decrease in central
vault under photopic conditions, as it causes ICL move-
ment posteriorly towards the crystalline lens. These find-
ings have been supported by Du et al. [16] who
demonstrated similar outcomes during pharmacological
accommodation with the use of topical pilocarpine. Add-
itionally, the central thickness of the crystalline lens is
well known to increase with age [25–27], and a thicker
lens may contribute to anterior protrusion of the front
surface of the crystalline lens. Garcia-Feijoo et al. [28]
concluded that the ICL haptics are typically finally
located at either the ciliary sulcus or the ciliary body.
Kojima et al. [21] showed that 35.3 % of phakic IOLs
were fixated in the ciliary body, while Choi et al. [29]
demonstrated that 64.7 % of phakic IOL haptics were
fixated in the ciliary sulcus. When the fixation location
is changed from the ciliary body to the ciliary sulcus, the
vault may decrease.
In our study, pupil movement demonstrated to be a
critical factor in vault change. In line with the results of
Seo et al. [30], postoperative vault was associated with
preoperative ACD and WTW, horizontal and vertical
STS in eyes implanted with ICL V4 and ICL V4c. There
were no differences of the preoperative factors corre-
lated with postoperative vault between the ICL V4 and
ICL V4c groups, suggesting that the presence of the
central hole and the varying sizes of ICL V4 and ICL
V4c were not a factor correlated with vault. The size of
the ICL pIOLs was determined based on the patient’s
WTW distance and ACD, therefore, postoperative vault
is likely to be associated with ACD and WTW distance.
ICL haptics was placed in the ciliary sulcus and the dis-
tance of sulcus to sulcus was highly correlated with the
distance of white-to-white, so the vault is associated
with the horizontal and vertical STS. However, the
ocular axis was not an influence factor of the vault in
our study although it may be correlated with the ACD
and the space of posterior chamber. Previous studies
[31] had showed that a statistically significant positive
correlation between axis length and ACD in normal
and long eyes(<27.5 mm) but not in extremely long
eyes (≥27.5 mm), while our study population were
moderate to high myopia with long and extremely long
axis (25.01 ~ 32.19 mm). Also, the ocular axis was cor-
related with ACD in neither ICL V4 nor ICL V4c group
in our study (r = 0.01, P = 0.96; r = 0.31, P = 0.06,
respectively).
There were several limitations in our study. Initially,
the ICL diameter was chosen according to the WTW
diameter, not according to the sulcus-to-sulcus diameter,
which is reported to be a more accurate measure for the
selection of ICL size [29]. The second limitation of this
study was that we did not measure the crystalline lens
thickness and the fixed position of the ICL haptics. An-
other limitation was that our observation period was
short and inadequate to determine long-term changes in
vault. Further study with a longer follow-up period after
surgery is required to ascertain the vault changes of ICL
V4 and ICL V4c and the factors affecting vault in the
long-term.
Conclusions
In conclusion, our results demonstrated the dynamic
and natural early changes in vault of eyes in the 1-
month period immediately following ICL V4 and ICL
V4c implantation and the relevant factors affecting
vault. We concluded that pupil size change is a critical
factor in vault change, and that preoperative ACD,
horizontal corneal diameter, horizontal and vertical
sulcus-to-sulcus are contributing factors affecting the
vault postoperatively. Overall in both groups, there was
a trend for the phakic IOL vaults to increase from
1 day to 1 week after surgery in response to an increase
in pupil size, with the vault tending to stabilize from
1 month postoperatively. Even when the vault was very
low and the ICL was close to the front surface of the
crystalline lens, there was never any need to exchange
the lens in the early period after ICL implantation, es-
pecially for ICL V4c implantation, as the 360 μm cen-
tral hole allows for the natural flow of aqueous humor
and may also reduce the risk of anterior capsular opaci-
fication and cataract formation. In these instances,
close observation may be sufficient. In order to reduce
the risk of complications following ICL implantation,
the relevant contributing preoperative factors should be
considered when selecting an ICL design and size, espe-
cially in eyes with deeper ACD, larger WTW and STS
distances that tend towards higher postoperative phakic
IOL vault.
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Additional file
Additional file 1: ICL V4, ICL V4c, respectively. Preoperative parameters,
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has 2 excels named preoperative parameters and vault, respectively. All the
preoperative parameters of ICL V4 and ICL V4c are recorded in the excel
“preoperative parameters” and the postoperative vault and the pupil size
and their changes are recorded in the excel “vault”. (ZIP 25 kb)
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